Skip to content

A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way

A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07129122
Enrollment
1
Registered
2025-08-19
Start date
2025-07-31
Completion date
2025-08-02
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Paravalvular Leaks (PVL)

Brief summary

The investigators will perform closure the mitral paravalvular leak in patient with mechanical aortic and mitral valve.

Detailed description

The mitral mitral paravalvular leak closure access are left atrial and transapical in patient with mechanical aortic and mitral valve. In this case the investigators will use interventricular septal access.

Interventions

OTHERTransventricular access

Transventricular access will perform with LBBAP lead from left subclavian way.

Sponsors

Bursa Postgraduate Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Had mitral paravalvüler leak Had mitral and aortic mechanical valve

Exclusion criteria

* Not suitable for left subclavian access Active infection

Design outcomes

Primary

MeasureTime frame
mitral paravalvüler leak closure sucsess2 day

Other

MeasureTime frame
mitral paravalvüler leak closure sucsess without complication2 day

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026